Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quinone analogues regulate mitochondrial substrate competitive oxidation.

Jean-Jacques Brière1, Dimitri Schlemmer, Domique Chretien

  • 1Unités de Recherches sur les Handicaps Génétiques de l'Enfant (INSERM U393), Hôpital Necker-Enfants Malades, 149, rue de Sèvres, 75015 Paris, France.

Biochemical and Biophysical Research Communications
|March 27, 2004
PubMed
Summary

Quinone derivatives show therapeutic potential for mitochondrial diseases, but their effectiveness hinges on specific interactions with the respiratory chain. Tailoring quinone analogues to target specific dehydrogenases is crucial for optimizing treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analytical feasibility of linezolid quantification by LC-MS/MS using dried plasma spot microsampling.

International journal of antimicrobial agents·2026
Same author

Discussing the future of mitochondrial biochemistry.

Trends in biochemical sciences·2025
Same author

Mitochondrial heat production: the elephant in the lab….

Trends in biochemical sciences·2025
Same author

Sengers syndrome caused by biallelic TIMM29 variants and RNAi silencing in Drosophila orthologue recapitulates the human phenotype.

Human genomics·2025
Same author

Mitochondria: great balls of fire.

The FEBS journal·2024
Same author

Author Correction: miR-379 links glucocorticoid treatment with mitochondrial response in Duchenne muscular dystrophy.

Scientific reports·2024

Area of Science:

  • Biochemistry
  • Mitochondrial Biology
  • Pharmacology

Background:

  • Quinone derivatives are investigated for treating mitochondrial diseases.
  • Their therapeutic efficacy is linked to their side chains and interaction with the respiratory chain.

Purpose of the Study:

  • To comparatively analyze the effects of four quinone derivatives on mitochondrial respiration.
  • To understand how quinone hydrophobicity influences their interaction with respiratory chain complexes.

Main Methods:

  • Studied the impact of menadione, duroquinone, idebenone, and decylubiquinone on NADH and succinate oxidation in sub-mitochondrial fractions.
  • Assessed electron flow diversion from Complex I and oxygen uptake stimulated by succinate.

Main Results:

Related Experiment Videos

  • Less hydrophobic quinones (menadione, duroquinone) poorly affected overall electron flow but diverted electrons from Complex I.
  • More hydrophobic quinones (idebenone, decylubiquinone) stimulated succinate oxidation.
  • Idebenone favored succinate oxidation over NADH oxidation, while decylubiquinone had a mixed effect on NADH oxidation.

Conclusions:

  • The specific effects of quinone analogues on individual respiratory chain dehydrogenases must be considered for therapeutic applications.
  • Hydrophobicity plays a key role in determining the interaction profile of quinone derivatives with the mitochondrial respiratory chain.